Infections should be considered a "health hazard" in people living with diabetes, with experts warning that current clinical guidelines fail to reflect a substantial but underrecognized burden of illness, hospitalization ...
45 minutes ago
0
0
Chromosomal instability is a common feature in many solid tumors and is associated with greater aggressiveness. For years, its main contribution to cancer was thought to be driving the evolution of tumor genomes, causing ...
3 hours ago
0
2
Autism spectrum disorder (ASD), commonly referred to as autism, is a neurodevelopmental condition characterized by differences in social interactions, communication, behavior and the processing of sensory stimuli. Notably, ...
For a long time, the likelihood of surviving pancreatic cancer has been extremely low. For patients who were diagnosed with metastatic pancreatic cancer between 2015 and 2021, about 97% died within five years of their diagnosis.
1 hour ago
0
0
A phase 1 clinical trial testing the safety of a leishmaniasis vaccine is set to begin in the coming months—the first vaccine created to protect against the disfiguring skin disease common in tropical regions of the world ...
3 hours ago
0
1
A combination of two widely available anti-rheumatic drugs offers the first effective and affordable treatment for patients with Sjögren's disease with systemic disease activity, according to new results from a clinical trial ...
3 hours ago
0
1
A research team has developed technology that uses artificial intelligence to analyze electroencephalogram signals triggered by thermal stimuli and objectively classify pain intensity. The study is published in IEEE Transactions ...
2 hours ago
0
0
A team of experimental oncology researchers at the University of Alberta is shedding light on how the deadly brain cancer glioblastoma spreads. In newly published research, they identify a potential treatment target to slow ...
5 hours ago
0
4
A vaccine targeting a broad range of viruses that was designed using artificial intelligence had a "modest" effect on immune systems in a small, early trial, according to a new study.
12 hours ago
0
14
In 2025, the European Medicines Agency approved two antibodies for Alzheimer's disease: lecanemab (LeqembiTM, from Biogen) and donanemab (Kisunla, from Eli Lilly and Co.), both based on immunotherapy (the use of molecules ...
10 hours ago
0
4
